Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyra Therapeutics Inc. logo

Chief Financial Officer Cavalier Jason was granted 100,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LYRA· Lyra Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYRA (Lyra Therapeutics Inc.) and more on Quantisnow.